Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Oncology

• Publication date

  2010-09-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2010.28.6674PMID 20713849PMCID PMC2953973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction: Reproducibility of Plasma and Urine Biomarkers among Premenopausal and Postmenopausal Women from the Nurses' Health Studies

  2011cited by this paper
• Meta-analysis of vitamin D, calcium and the prevention of breast cancer

  2010cited by this paper
• CEBP Focus: Biomarkers and Biospecimens

  2010cited by this paper
• Reproducibility of Plasma, Red Blood Cell, and Urine Biomarkers among Premenopausal and Postmenopausal Women from the Nurses' Health Studies

  2010cited by this paper
• Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma

  2009cited by this paper
• Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.

  2009cited by this paper
• Meta‐analysis: longitudinal studies of serum vitamin D and colorectal cancer risk

  2009cited by this paper
• High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy.

  2009cited by this paper
• A prospective investigation of serum 25‐hydroxyvitamin D and risk of lymphoid cancers

  2009cited by this paper
• Vitamin D and Non-Hodgkin Lymphoma Risk in Adults: A Review

  2009cited by this paper
• Nonclassic actions of vitamin D.

  2009cited by this paper
• Correlation among 25-hydroxy-vitamin D assays.

  2008cited by this paper
• Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium

  2008influential reference
• 25-hydroxyvitamin D levels and the risk of mortality in the general population.

  2008influential reference
• Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.

  2008cited by this paper
• Vitamin D deficiency.

  2007cited by this paper
• High prevalence of vitamin D inadequacy and implications for health.

  2006cited by this paper
• A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.

  2006cited by this paper
• Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.

  2006cited by this paper
• Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

  2006cited by this paper
• Vitamin D and prevention of colorectal cancer.

  2005cited by this paper
• The Vitamin D requirement in health and disease.

  2005cited by this paper
• Follicular lymphoma international prognostic index.

  2004cited by this paper
• Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands.

  2003cited by this paper
• Hypovitaminosis D in medical inpatients.

  1998cited by this paper
• Hypovitaminosis D in medical inpatients.

  1998cited by this paper
• Flexible smoothing with B-splines and penalties

  1996cited by this paper
• Structure-function relationships in the vitamin D endocrine system.

  1995cited by this paper
• Calcitriol Production in Hypercalcemic and Normocalcemic Patients with Non-Hodgkin Lymphoma

  1994cited by this paper
• The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma.

  1993cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma.

  1991cited by this paper
• 1,25-dihydroxyvitamin D3 receptors in human leukocytes.

  1983cited by this paper
• Vitamin D deficiency.

  1979cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Vitamin D’s Impact on Cancer Incidence and Mortality: A Systematic Review

  2025cites this paper
• Recent advances in infections as risk factors for lymphoma: a review of the effects of viral, bacterial, and fungal infections in lymphoma

  2025cites this paper
• Influence of Vitamin D and Its Analogues in Type-B Lymphomas

  2025cites this paper
• Association of Selective VDR Gene Polymorphisms with Diffuse Large B-Cell Lymphoma (DLBCL) in a South Indian Population

  2025cites this paper
• 1α,25(OH) 2D 3 prevents CD19 CAR-T cell exhaustion and differentiation via VDR-dependent transcriptional reprogramming.

  2025cites this paper
• Effect of Vitamin D and Skeletal Muscle Mass on Prognosis of Patients with Diffuse Large B-Cell Lymphoma

  2024cites this paper
• Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers.

  2024cites this paper
• Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials

  2024cites this paper
• Vitamin D in Cutaneous T-Cell Lymphoma

  2024cites this paper
• Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial

  2024cites this paper
• A Systematic Review Assessing the Impact of Vitamin D Levels on Adult Patients with Lymphoid Malignancies

  2023influential citation
• Integrative Approaches in the Treatment of Patients Affected by Lymphoma

  2023cites this paper
• Hypovitaminosis D in Haematological Malignancies: Cause or Consequence?

  2023cites this paper
• DLBCL: Who is high risk and how should treatment be optimized?

  2023cites this paper
• 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas

  2023cites this paper
• Serum Level of Vitamin D in Patients with Salivary Gland Tumors

  2023cites this paper
• Vitamin D and Sjögren’s Disease: Revealing the Connections—A Systematic Review and Meta-Analysis

  2023cites this paper
• Prognostic significance of 25-hydroxyvitamin D levels in patients with peripheral T-cell lymphoma

  2023cites this paper
• Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma: Vitamin D insufficiency and CAR-T in LBCL.

  2022cites this paper
• Preinduction Serum Vitamin D3 Levels and Induction Chemotherapy Remission Rates in Patients with Acute Leukemia

  2022cites this paper
• Effect of Vitamin D on Graft-versus-Host Disease

  2022cites this paper
• Responsible enzymes for metabolizing vitamin D in patients with acute leukemia and the relationship with treatment outcomes: a case-control study

  2022cites this paper
• Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method

  2022cites this paper
• Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome

  2022cites this paper
• Newly Diagnosed Children with Cancer Have Lower 25-Vitamin D Levels than Their Cancer-Free Peers: A Comparison across Age, Race, and Sex

  2022cites this paper
• Vitamin D-Binding Protein and Acute Myeloid Leukemia: A Genetic Association Analysis in Combination with Vitamin D Levels

  2022cites this paper
• The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies

  2022cites this paper
• Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

  2021cites this paper
• Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus?

  2021cites this paper
• Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies

  2021cites this paper
• Epidemiology of Non-Hodgkin’s Lymphoma

  2021cites this paper
• Impact of vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis

  2021influential citation
• 25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma.

  2021cites this paper
• Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B‐cell lymphoma

  2020cites this paper
• Vitamin D status in children with leukemia, its predictors, and association with outcome

  2020cites this paper
• To D or not to D: vitamin D in hematopoietic cell transplantation

  2020cites this paper
• Role of Vitamins A and D in BCR-ABL Arf−/− Acute Lymphoblastic Leukemia

  2020cites this paper
• Bioavailable 25(OH)D level is associated with clinical outcomes of patients with diffuse large B-cell lymphoma: An exploratory study.

  2020cites this paper
• The Role of Vitamin D in Veterinary Oncology: A Literature Review

  2020cites this paper
• Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma

  2020cites this paper
• Vitamin D level and endogenous DNA damage in patients with cancers in Duhok city, KRG-Iraq

  2020cites this paper
• Twenty years later: has cell of origin testing in diffuse large B cell lymphoma run its course?

  2020cites this paper
• Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels

  2020cites this paper
• The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma

  2020cites this paper
• Magnesium: The overlooked electrolyte in blood cancers?

  2020cites this paper
• Association between anthropometry and lifestyle factors and risk of B‐cell lymphoma: An exposome‐wide analysis

  2020cites this paper
• Effect of serum vitamin D deficiency in the prevalence of haematological malignancies

  2020cites this paper
• Antitumor effects and mechanisms of 1,25(OH)2D3 in the Pfeiffer diffuse large B lymphoma cell line

  2019cites this paper
• Ecological Evidence for Lower Risk of Lymphoma with Greater Exposure to Sunlight and Higher Altitude

  2019cites this paper
• Vitamin D supplementation does not affect survival in patients with Hodgkin’s lymphoma

  2019cites this paper
• Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma.

  2019cites this paper
• Safety and Tolerability of Targeted Medical Nutrition for Cachexia in Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Controlled Pilot Trial

  2019cites this paper
• Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma

  2019cites this paper
• S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL

  2019cites this paper
• Effects of vitamin D3 and its chemical analogs on the growth of Hodgkin’s lymphoma, in vitro

  2019cites this paper
• Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies

  2018cites this paper
• 25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it?

  2018influential citation
• Einfluss von Vitamin-D auf Cathelicidin, einen Marker für die Aktivierung der ADCC durch Rituximab bei Patienten mit hochmalignen B-Zell Lymphomen

  2018cites this paper
• Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma

  2018cites this paper
• VITAMIN D 2 LEVELS IN TYPE-2 DIABETES MELLITUS PATIENTS IN ANDAMAN AND NICOBAR ISLANDS

  2018cites this paper
• Mycosis Fungoides and Vitamin D Status: Analyses of Serum 25-Hydroxyvitamin D Levels and Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene.

  2018cites this paper
• Follicular and Diffuse Large B-Cell Lymphoma - Studies of Primary Treatment and Prognostic Factors

  2018cites this paper
• DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms

  2018cites this paper
• Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.

  2018cites this paper
• Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T‐cell lymphoma

  2018cites this paper
• Vitamin D and its receptor polymorphisms: New possible prognostic biomarkers in leukemias

  2018cites this paper
• The association of physical activity before and after lymphoma diagnosis with survival outcomes

  2018cites this paper
• Relationship between serum 25-hydroxyvitamin D and red blood cell indices in German adolescents

  2018cites this paper
• The use of inexpensive broad spectrum lower toxicity therapeutics in chronic lymphocytic leukemia.

  2017cites this paper
• FCGR3A/2A polymorphisms and diffuse large B‐cell lymphoma outcome treated with immunochemotherapy: a meta‐analysis on 1134 patients from two prospective cohorts

  2017cites this paper
• Hematologic malignancy incidence and cause-specific mortality in the Women’s Health Initiative randomized controlled trial of calcium and vitamin D supplementation

  2017cites this paper
• Patterns and Prediction of Competing Causes of Mortality in Older Adults Diagnosed with Indolent Non-Hodgkin Lymphoma

  2017cites this paper
• ESPEN guidelines on nutrition in cancer patients.

  2017cites this paper
• The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis

  2017cites this paper
• Incidence of hematologic malignancy and cause‐specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation

  2017cites this paper
• Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy

  2017influential citation
• High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome

  2017cites this paper
• Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression

  2017cites this paper
• Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients

  2017cites this paper
• Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma

  2017cites this paper
• Vitamin D in hematological disorders and malignancies

  2017cites this paper
• International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma.

  2017cites this paper
• Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

  2017cites this paper
• Facteurs épidémiologiques influençant la survie dans le lymphome à cellules du manteau

  2017cites this paper
• A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival

  2017cites this paper
• Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid Malignancies.

  2017cites this paper
• Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia

  2017cites this paper
• Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia.

  2016cites this paper
• C–C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation

  2016cites this paper
• Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

  2016cites this paper
• Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.

  2016cites this paper
• Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D

  2016cites this paper
• [Vitamin D and parathyroid hormone levels and bone mineral density in patients undergoing hematopoietic cell transplantation].

  2016cites this paper
• Micronutrients in Oncological Intervention

  2016cites this paper
• Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis.

  2016cites this paper
• Season of diagnosis is associated with overall survival in patients with diffuse large B‐cell lymphoma but not with Hodgkin's lymphoma – A population‐based Swedish Lymphoma Register study

  2016cites this paper
• Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma

  2016cites this paper
• Serum Vitamin D and Vitamin D Receptor Gene Polymorphism in Mycosis Fungoides Patients: A Case Control Study

  2016cites this paper
• Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.

  2016cites this paper
• The mTORC1 Inhibitor Everolimus Combined with R-CHOP-21 for New Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Safety and Efficacy Results of a Phase I and Feasibility Trial NCCTG 1085 (Alliance)

  2016cites this paper